B Böttcher

No ORCID on file · 5 papers in corpus
2026
·doi:10.1055/s-0046-1828247
2016
·doi:10.1055/s-0035-1570042

Die hormonellen Veränderungen im weiblichen Zyklus beeinflussen eine Vielzahl der Körperfunktionen und können spezifische Erkrankungen hervorrufen bzw. deren Symptomatik verstärken. Eine klassische zyklusabhängige Erkrankung ist die Dysmeno…

observational 2015
Archives of gynecology and obstetrics ·doi:10.1007/s00404-015-3789-8

PURPOSE: Several studies on the quality of life in patients with endometriosis have been performed with conflicting results. This cross-section survey examines the influence of endometriosis on the psychological well-being and the quality o…

observational 2014
Archives of gynecology and obstetrics ·doi:10.1007/s00404-014-3437-8

PURPOSE: In a series of publications, we had developed the concept that uterine adenomyosis and pelvic endometriosis as well as endometriotic lesions at distant sites of the body share a common pathophysiology with endometriosis constitutin…

nonrandomized-trial 2014
Human Reproduction ·doi:10.1093/humrep/deu205

STUDY QUESTION: What is the safe and pharmacodynamically active dose range for PDC31 (prostaglandin F2α receptor inhibitor) in patients with primary dysmenorrhea (PD)? SUMMARY ANSWER: The 1 mg/kg/h dose of PDC31 appears to be safe and pote…